Insulin attenuates the contractile responses of vascular smooth muscle (VSM) to various agonists. Insulinopenic and insulinresistant rats lack this normal attenuation of vascular contractile responses. To study this attenuating mechanism, the effects of insulin on calcium (Ca2") responses of cultured VSM cells (a7r5) to arginine vasopressin (AVP) and membrane potential were investigated. Insulin (1 and 100 mU/ml) shifted AVP dose-response curves to the right, reducing relative potency of AVP by 16-fold and 220-fold, respectively. Responses to AVP were significantly attenuated within 30 min of insulin application. The AVP-elicited rise in [Ca2"I] was partially dependent upon extracellular Ca2". AVP-elicited inward current was reduced by 90 min of insulin treatment (100 mU/ml), from a peak current of -103±27 pA (normal) to -37±15 pA (insulin treated). Peak voltage-dependent Ca2"-dependent inward current was unaffected by insulin; however, the current-voltage curve was shifted 16±3 mV to the right by insulin. Thus, insulin may reduce VSM contractile responses by attenuating agonistmediated rises in ICa2"I mediated, in part, by reductions in Ca2" influx through both receptor-and voltage-operated channels. (J. Clin. Invest. 1991. 88:1230-1236
Introduction
Recent observations have suggested that impaired cellular responses to insulin are associated with increased vascular smooth muscle (VSM)' tone (1) (2) (3) (4) , the hallmark of the hypertensive state in both type I and type II diabetes (4) (5) (6) . Recently reported studies demonstrated that insulin, in physiological doses, shifted the EDsO for vascular contractile responses to phenylephrine and serotonin to higher concentrations without changing the maximum response (7) . Similarly, insulin attenuated vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein (8) . Furthermore, A preliminary report of this work has been published in abstract form in 1991 (J. Cell. Biochem. [Suppl.15C]:115). 1 . Abbreviations used in this paper: MANOVA, measures analysis of variance; PSS, physiological salt solution; VSM, vascular smooth muscle; VSMC, VSM cells. vessels from both insulinopenic (9) and insulin-resistant rats (7, 10) demonstrated enhanced vasoconstrictive responses to various agonists. Although maximal vasoconstrictive responses of isolated vessels to agonists were the same in insulinresistant and normal rats, the EDs, for responses to phenylephrine, serotonin, and potassium chloride were shifted to lower concentrations in vessels from insulin-resistant rats (7) . Thus, insulin appears to attenuate the vascular contractile response to both receptor and voltage-dependent mechanisms.
Calcium (Ca2") is generally acknowledged to be important in mediating VSM contractile responses (I1). Insulin could accordingly attenuate VSM contractility by altering movement of Ca2l into VSM cells or by affecting intracellular release of Ca2" from storage sites. Indeed, in skeletal muscle, insulin has been demonstrated to produce hyperpolarization, to reduce Ca2" currents, and to shorten Ca2"-mediated action potentials (12) , and in VSM tissue insulin regulates Ca2' efflux (13) . Our study was designed to examine the effects of insulin on both agonist and voltage-mediated Ca2' responses in cultured VSM cells (VSMC).
Methods
Preparation of VSMC. A7r5 VSMC (derived from embryonic DBIX rat thoraic aorta) were obtained from American Type Culture Collection, Rockville, MD. Cells were maintained under 5% CO2 and 100% humidity at 370C in growth medium (DMEM supplemented with 9% fetal bovine serum [FBS] , 0.2% Tylosin, 100 U/ml penicillin, and 0.1 mg/ml streptomycin). Serial passages were obtained by treating confluent cultures with 0.2% trypsin, 1 mM EGTA in Ca2+/Mg2+-free HBSS (Sigma Chemical Co., St. Louis, MO) for 10 min at 370C. Released cells were centrifuged at 1,200 rpm for 5 min, and the cell pellet was then resuspended in DMEM.
For VSMC Ca2+ studies, confluent cells were plated onto glass cover slips (13 X 50 mm) at a density of 1 x 106 cells/ml in 35 x 10 mm petri dishes (Falcon Labware, Becton Dickinson & Co., Oxnard, CA). Upon reaching confluence (usually 3-4 d), the growth medium was replaced with a 0.2% FBS medium containing DMEM supplemented with 0.2% FBS and antibiotics (as above). For whole cell patch clamp recording, confluent cells were replated directly onto 35 X 10 mm petri dishes (Falcon) and incubated for 20-25 h in 0.2% FBS medium before insulin addition and whole cell recording.
Cell Ca"+ measurements. The effects ofinsulin on [Ca2+]i responses to arginine vasopressin (AVP) were evaluated using both static (nonperfused) and constant perfusion systems. For static experiments, confluent cell monolayers were maintained in 0.2% FBS medium for 12-24 h at 37°C, 100% humidity, and 5% CO2. The medium was then replaced with 0.2% FBS medium containing various concentrations of human synthetic insulin (0-100 mU/ml). After 60 min, fura 2-AM dissolved in DMSO was added to achieve final concentrations of 3 ALM fura 2-AM and 0.001% DMSO. Cells were incubated for a further 60 min in the presence of insulin and fura 2-AM. Cover slips containing the fura-loaded cells were rinsed twice at 37°C in a pH 7.4 physiological salt solution (PSS) containing (in mM) 145 NaCl, 5 KCl, 10 Hepes, 1 Mg2SO4, 0.5 Na2HPO4, 6 glucose, and 1.5 CaCI2. Deesterification of fura-2-AM to fura-2, the calcium-sensitive form of the compound, occurred during the 60-min loading period and the subsequently described procedures, lasting -15 min. Cover slips were then placed in a quartz nonfluorescing cuvette containing 3 ml PSS maintained at 370C, and additions of AVP were carried out using a micropipette.
For constant perfusion experiments, cells were loaded with fura 2-AM (without insulin) as above. The cuvette was fitted with an acrylic perfusion apparatus through which media (maintained at 370C and gassed with 95% 02/5% CO2) were constantly delivered by peristaltic pump at a rate of 6 ml/min. The cuvette chamber was maintained at 370C with a circulating water bath. Perfusion buffers (PSS, PSS + insulin, or Zero-Ca-PSS) and the corresponding AVP-containing perfusion buffers were added using a four-way stainless steel valve located upstream of the peristaltic pump. Fura-loaded cells were initially superfused with PSS for 10 min before any experimentation. CaCl2 was excluded in preparing Zero-Ca-PSS.
Fluorometric data were obtained using a dual excitation monochrometer spectrofluorometer (SPEX Fluorolog; Spex Industries, Inc., Edison, NJ). Excitation wavelengths of 340 and 380 nm and an emission wavelength of 505 nm were used with monochrometer slits set at 3 nm. Calibration ofthe intracellular Ca2+ signal was accomplished using an F,,, signal obtained with 30 AM Br-A23187, and Fi.... signal obtained with 0.5 mM MnC12 and Kd = 224 nM. Br-A23 187 is a nonfluorescent calcium ionophore that is also permeable to Mn2+ (14) . Mn2+ is an effective quencher of fura-2 fluorescence (15) . The value of Kd is from Grynkiewicz et al. (15) , as measured in a medium of -155 mM ionic strength (KCl/NaCVK-3-(4-Morpholino)propane sulfonic acid solution). These data were fitted to the formula of Grynkiewicz et al. ratio from these prior calibrated experiments was applied to experiments in which a7r5 cells were prepared and loaded with fura-2 with identical procedures. Since such Ca2`levels may be viewed as only "nominal," results were analyzed for each cover slip relative to its own baseline or initial response levels (where more than one response was elicited), as described in each figure caption.
Whole cell voltage clamp. A plexiglass insert with a central hole -I cm in diameter was clamped into the 35-mm petri dish, forming a small subchamber -0.4 ml in volume. Cells in the subchamber were constantly superfused at -6 ml/min with a pH 7.4 solution containing (in mM) 113 NaCI, 4 Fig. 2 A. Data from 13 cover slips are summarized in Fig. 2 Fig. 3 A. 1 min after beginning perfusion in zero-Ca-PSS the response to 10 nM AVP was only 37±14% ofthe response to similarly timed AVP applications in normal medium (MANOVA over all times, P < 0.01; univariate comparison to PSS at 1 min, P < 0.01, one-tailed). The AVP-mediated rise in [Ca2+]i remained depressed when tested at 6 (P < 0.05, one-tailed) and 11 (P < 0.01, one-tailed) min after onset ofCa2"-free media (Fig. 3 B) . Within the time period examined, Zero-Ca-PSS caused no significant change in base-
Insulin reduces A VP-elicited current. AVP elicited a long lasting inward current at the holding potential of-80 mV (Fig.  4 A) . Although AVP also elicited inward current in insulintreated cells, the peak current was markedly reduced compared to control cells. Peak current elicited by 100 nM AVP was -103±27 pA in control cells (n = 12), whereas the peak AVP response in cells treated with insulin for 1.5 h with 100 mU/ml insulin was only -37±15 pA (n = 14) (P < 0.05) (Fig. 4 B) .
Insulin shifts the voltage dependence of voltage-dependent inward current. Depolarization elicited inward current in both insulin-treated and control cells (Fig. 5 A) . Although pipette and bath solutions were not chosen to isolate voltage-dependent Ca2" current, the inward current so generated could nevertheless be completely eliminated by removal of extracellular Ca2 . In addition, this current could be increased by substituting barium for Ca2' in the bathing solution (data not shown), indicative of voltage-dependent Ca2' current. Current-voltage curves obtained using the pulse protocol are illustrated in Fig.  5 . There was no significant difference between the peak inward current for control cells (-525±292 pA, n = 9) and insulintreated cells (-525±129 pA, n = 9); however, inward current began to activate at a more negative membrane potential in control cells than in insulin-treated cells. Two representative cells are shown in Fig. 5 A. The peak current elicited by -40 mV in the control cell was approximately one-third as large as the maximum current that could be elicited in the same cell (the response to -10 mV). In contrast, in the insulin-treated cell, depolarization to -40 mV elicited no voltage-dependent response, and a one-third maximal response was not attained until a depolarization of -30 mV. 12 the pulse method) the ramp command should give a better resolution of the membrane potential at which inward current TIME POST-TREATMENT (min) begins to activate than does the pulse method. As with the pulse zero-Ca2+ medium on the AVP-induced rise in protocol, the membrane potential at which inward current be-
4C. (A) Representative fluorometric record illus-
gan to activate in insulin-treated cells was shifted significantly to 10 nM AVP in the presence of extracellular to the right. A rise in inward current to 20% of the maximum 7edium) and 1, 6, and 11 min after beginning per-response occurred with a minimal depolarization of -43±3 ium (0 Ca2" medium). (B) Summary of AVP remV for control cells and -27±3 mV for insulin-treated cells (P ium medium (six cover slips), expressed as percent < 0.05). Univariate analysis ofvariance comparing control and se elicited in normal medium, compared to AVP insulin-treated cells gave significance levels of <0.04 for all t similar intervals in normal medium (PSS) membrane potentials between -54 mV and -25 mV.
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Discussion current-voltage curves (normalized to maximum elicited current as described in the figure caption) for nine control and nine insulin-treated cells. The average current-voltage curve for insulin-treated cells is shifted to the right compared to control cells. The minimal depolarization that elicited a current of 20% of the maximal response was -44±4 mV in control cells and -28±4 mV in insulin-treated cells (t test, P < 0.05). Furthermore, significantly more current was elicited in control cells than in insulin-treated cells at -40 mV and -30 mV (Fig.   5 B) . (4) (5) (6) and in both insulinopenic (9) and insulin-resistant (7) animal models may result from de- (27) demonstrated that AVP activates a nonspecific cation channel in a7r5 cells that induces inward current similar to our observations (Fig. 4) duced increase in [Ca2+]j is due to Ca2" influx via a receptoroperated channel. Since insulin substantially reduces this nonspecific cation current (Fig. 4) , at least a portion of insulin attenuation of VSMC [Ca2J]i responses to AVP may be attributed to reduced Ca2" influx through receptor-operated channels. Whether this is due to a downregulation of AVP receptors, a change in coupling of the AVP receptor to intracellular mediators, or a reduction in the response ofchannels activated by them is a question for future research.
Data from this study also show that insulin causes a rightward shift of the current-voltage curves for overall current in a7r5 VSMC without changing the maximum current elicited. The shift in the voltage dependence without a change in peak current accords well with previous observations on muscle strips that the effect ofinsulin is to shift dose-response curves to the right without changing the maximum response (7). A7r5 cells have previously been shown to have voltage-dependent Ca2+ channels (27, 28) . Although recording conditions in our study were not chosen to isolate Ca2r current, the inward current is Ca2' dependent (28) . The shift in the total current may result either from a decrease in the activation of Ca2' current or an increase in activation ofK+ current between -25 and -45 mV, where the difference between insulin-treated and control cells is most evident. In A large number of studies have shown that hypertension is associated with hyperinsulinemia (19, 29) . One interpretation of this association is that insulin causes the hypertension. Suggested mechanisms include a direct sodium-retaining action of insulin on the kidney (30, 31) and an insulin-stimulated rise in sympathetic nervous system activity (32, 33 
